arginine has been researched along with bibo 3457 in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (6.25) | 18.2507 |
2000's | 41 (51.25) | 29.6817 |
2010's | 27 (33.75) | 24.3611 |
2020's | 7 (8.75) | 2.80 |
Authors | Studies |
---|---|
Doods, HN; Eberlein, W; Engel, W; Rudolf, K; Wieland, HA | 1 |
Gehlert, DR; Sajdyk, TJ; Vandergriff, MG | 1 |
Beauverger, P; Boutin, JA; Duhault, J; Félétou, M; Galizzi, JP; Nicolas, JP; Rodriguez, M | 1 |
Doods, HN; King, PJ; Widdowson, PS; Williams, G | 1 |
Capurro, D; Huidobro-Toro, JP | 1 |
Akinsanya, K; Aubert, ML; Broqua, P; Galyean, R; Hayward, A; Junien, J; Raposinho, PD; Schteingart, C | 1 |
Dumont, Y; Quirion, R | 1 |
Ciccocioppo, R; Massi, M; Polidori, C; Regoli, D | 1 |
Goto, K; Kunii, K; Matsuzaki, I; Miwa, Y; Nambu, T; Sakai, A; Sakurai, T; Tsujino, N; Yamanaka, A | 1 |
Cadieux, A; Doods, H; Dumont, Y; Fournier, A; Quirion, R | 1 |
Harro, J; Kask, A; Rägo, L; Schiöth, HB; Wikberg, JE | 1 |
Boulanger, M; Boutin, JA; Chamorro, S; Della Zuana, O; Douillet, E; Duhault, J; Fauchère, JL; Félétou, M; Germain, M; Husson, B; Renard, P; Tisserand, F; Vega, AM | 1 |
Harro, J; Kask, A | 1 |
French-Mullen, J; Gobbi, M; Moneta, D; Mulé, F; Ravizza, T; Vezzani, A | 1 |
Beierwaltes, WH; Carretero, OA; Dovgan, PS; Nypaver, TJ; Shin, LH | 1 |
Cox, HM; Herzog, H; Pollock, EL; Tough, IR | 1 |
Asakawa, A; Cheng, JT; Dobashi, R; Fujimiya, M; Inui, A; Kaga, T; Kasuga, M; Liu, IM; Morimoto, Y; Nishimura, N; Okita, M; Ueno, N | 1 |
Baudoin, FM; Lawrence, CB; Luckman, SM; Snape, AC | 1 |
Chaffer, CL; Morris, MJ | 1 |
Larhammar, D; Lecklin, A; Lundell, I; Männistö, PT; Paananen, L; Wikberg, JE | 1 |
Taiwo, OB; Taylor, BK | 1 |
Beck-Sickinger, A; Demuth, H; Dimitrijević, M; Kovacević-Jovanović, V; Stanojević, S; von Hörsten, S; Vujić, V | 1 |
Detheux, M; Dumont, Y; Kotani, M; Lannoy, V; Marcus, D; Mazarguil, H; Mollereau, C; Parmentier, M; Quelven, I; Quirion, R; Zajac, JM | 1 |
Audinot, V; Beauverger, P; Boutin, JA; Dromaint, S; Galizzi, JP; Imbert, J; Lamamy, V; Macia, C; Nicolas, JP; Rique, H; Rodriguez, M | 1 |
Carvajal, C; Dumont, Y; Gardell, L; Lai, J; Ossipov, MH; Porreca, F; Quirion, R; Zhang, ET | 1 |
Cox, HM; Herzog, H; Hyland, NP; Sjöberg, F; Tough, IR | 1 |
Brain, SD; Chu, DQ; Costa, SK; Cox, HM; Herzog, H | 1 |
Beck-Sickinger, A; Bedoui, S; Kawamura, N; Lin, Y; Miyake, S; Miyamoto, K; Oki, S; von Hörsten, S; Yamamura, T | 1 |
Clarke, IJ; Estrada, KM; Morris, MJ; Pompolo, S; Tilbrook, AJ | 1 |
Ishii, S; Kamegai, J; Oikawa, S; Shimizu, T; Sugihara, H; Tamura, H | 1 |
Beck-Sickinger, AG; Meyer, M; Ove Ogren, S; Spiess, J; Stiedl, O; Tovote, P; von Hörsten, S | 1 |
Denton, KM; Eppel, GA; Evans, RG; Luff, SE | 1 |
Ishii, S; Kamegai, J | 1 |
Flores, CM; Gibbs, JL; Hargreaves, KM | 1 |
Domin, H; Smiałowska, M; Wierońska, JM; Zieba, B | 1 |
Adewale, AS; Macarthur, H; Westfall, TC | 1 |
Asakawa, A; Fujimiya, M; Herzog, H; Inui, A; Kasuga, M; Meguid, MM; Miyazaki, J; Ninomiya, M; Ueno, N; Yuzuriha, H | 1 |
Macarthur, H; Westfall, TC; Wilken, GH | 1 |
Cox, HM | 1 |
Kuphal, KE; Pedrazzini, T; Solway, B; Taylor, BK | 1 |
Byku, M; Macarthur, H; Westfall, TC | 1 |
Davis, M; Gutman, AR; Ressler, KJ; Yang, Y | 1 |
Bartness, TJ; Dailey, MJ | 1 |
Akerberg, H; Chee, MJ; Colmers, WF; Cone, RD; Fan, W; Gruber, KA; Larhammar, D | 1 |
Bürki, H; Chaperon, F; Fendt, M; Imobersteg, S; Lingenhöhl, K; McAllister, KH; Orain, D; Uzunov, DP | 1 |
Adams-Deutsch, T; Heilig, M; Nair, SG; Navarre, BM; Pickens, CL; Shaham, Y | 1 |
Kostić, S; Puljak, L; Sapunar, D; Vukojević, K | 1 |
Bose, SC; Corder, G; Donahue, RR; Solway, B; Taylor, BK | 1 |
Chafetz, D; Maric, T; Schoela, N; Sedki, F; Shalev, U | 1 |
Menard, JL; Trent, NL | 1 |
Bastianetto, S; Benoit, CE; Dumont, Y; Flores, G; Fournier, A; Morales-Medina, JC; Quirion, R | 1 |
Cohen, H; Kaplan, Z; Kozlovsky, N; Liu, T; Mathé, AA; Zohar, J | 1 |
Cox, HM; Forbes, S; Herzog, H | 1 |
Baldock, PA; Enriquez, RF; Herzog, H; Lamghari, M; Sainsbury, A; Sousa, DM; Zhang, L | 1 |
Hanawa, T; Hori, A; Ito, N; Nagai, T; Oikawa, T; Yabe, T; Yamada, H | 1 |
Abdel-Samad, D; Ahmarani, L; Avedanian, L; Bkaily, G; D'Orléans-Juste, P; Jacques, D; Magder, S; Perreault, C | 1 |
Bernhardt, G; Buschauer, A; Holzammer, T; Kaske, M; Keller, M | 1 |
Bálint, Z; Crnkovic, S; Egemnazarov, B; Gattinger, N; Ghanim, B; Jain, P; Klepetko, W; Kovacs, G; Kwapiszewska, G; Marsh, LM; Olschewski, A; Schermuly, RT; Seay, U; Weissmann, N | 1 |
Cohen, H; Cohen, S; Kaplan, Z; Kozlovsky, N; Matar, MA; Mathé, AA; Vainer, E; Zohar, J | 1 |
Bernhardt, G; Buschauer, A; Keller, M; Schindler, L | 1 |
Ahlbrand, R; Baccei, ML; Dolgas, CM; Rush, J; Sah, R; Schmeltzer, S; Schurdak, J; Vollmer, LL | 1 |
Cabral, A; Perello, M; Portiansky, E; Sánchez-Jaramillo, E; Zigman, JM | 1 |
Brooks, VL; Cassaglia, PA; Shi, Z | 1 |
Kornhuber, J; Zoicas, I | 3 |
Bensellam, M; Cantley, J; Chan, JY; Dezaki, K; Grey, ST; Gurzov, EN; Herzog, H; Ip, CK; Kay, TW; Laybutt, DR; Lee, K; Loh, K; Nakata, M; Shi, YC; Thomas, HE; Waibel, M; Walters, S; Yada, T | 1 |
Clarke, IJ; Daniel, JA; Elsasser, TH; Foradori, CD; Jones, MA; Keisler, DH; Read, CC; Sartin, JL; Smith, JT; Steele, BP; Whitlock, BK; Zimmerman, AD | 1 |
Alencastre, IS; Barreiros, L; Barros, C; Domingues, MRM; Domingues, P; Lamghari, M; Melo, T; Segundo, MA; Silva, EMP; Varandas, PAMM | 1 |
Appel, CK; Christiansen, SH; Diaz-delCastillo, M; Falk, S; Heegaard, AM; Woldbye, DPD | 1 |
Gao, S; Gong, Y; Guo, F; Sun, X; Xu, L; Zhang, N | 1 |
Brooks, VL; Cassaglia, PA; Pelletier, NE; Shi, Z | 1 |
Doolen, S; Fu, W; Gutierrez, JJP; K Taylor, B; Nelson, TS; Santos, DF; Ye, N; Zhou, J | 1 |
Chen, W; Fu, W; Marvizon, JC; Taylor, BK | 1 |
Chi, X; Han, Y; Li, F; Li, Z; Qin, Y; Wang, Y; Xiao, J; Xie, W | 1 |
David, H; Hoang, JD; Salavatian, S; Swid, MA; Vaseghi, M; Yamaguchi, N | 1 |
Galic, S; Loh, K; Oakhill, JS; Onda, DA; Scott, JW; Yang, CH | 1 |
Bensellam, M; Enriquez, R; Gao, H; Gao, Z; Gou, L; Haigh, JJ; Herzog, H; Hughes, W; Ip, CK; Lau, J; Laybutt, DR; Lee, K; Loh, K; Nobis, M; Shi, YC; Timpson, P; Wang, QP; Wu, Q; Xia, Z; Yan, C; Zeng, T; Zhang, L | 1 |
Cimarosti, H; de Lima, TCM; Linartevichi, VF; Soares, ES; Vanz, F | 1 |
Ann-Onda, D; Eizirik, DL; Fynch, S; Galic, S; Herzog, H; Laybutt, DR; Levinger, I; Lin, X; Liu, X; Loh, K; Loudovaris, T; Moreno-Asso, A; Nadarajah, S; Oakhill, JS; Pappas, EG; Scott, JW; Shi, Y; Smith, C; Thomas, HE; Yang, CH | 1 |
1 review(s) available for arginine and bibo 3457
Article | Year |
---|---|
Regulation of Pancreatic β-Cell Function by the NPY System.
Topics: Animals; Arginine; Diabetes Mellitus; Humans; Insulin-Secreting Cells; Molecular Targeted Therapy; Neuropeptide Y; Receptors, Neuropeptide Y | 2021 |
79 other study(ies) available for arginine and bibo 3457
Article | Year |
---|---|
Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.
Topics: Animals; Arginine; Cricetinae; Cyclic AMP; Eating; Humans; Hypothalamus; Kidney; Male; Paraventricular Hypothalamic Nucleus; Rats; Receptors, Neuropeptide Y; Tumor Cells, Cultured | 1998 |
Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test.
Topics: Amygdala; Animal Communication; Animals; Anti-Anxiety Agents; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Social Behavior; Stereoisomerism | 1999 |
NPY receptor subtype in the rabbit isolated ileum.
Topics: Animals; Arginine; CHO Cells; Cricetinae; Humans; Ileum; In Vitro Techniques; Male; Muscle Contraction; Naphthalenes; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tetrodotoxin | 1999 |
Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
Topics: Agatoxins; Animals; Arginine; Autoreceptors; Biological Transport; Calcium Channel Blockers; Hypothalamus; Ligands; Male; Naphthalenes; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; omega-Conotoxins; Organ Culture Techniques; Peptide Fragments; Peptides; Peptides, Cyclic; Potassium; Pyrimidines; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Spider Venoms | 1999 |
The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Cardiovascular Agents; Carotid Arteries; Cats; Dose-Response Relationship, Drug; Ligation; Neuropeptide Y; Receptors, Neuropeptide Y | 1999 |
Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat.
Topics: Animals; Arginine; COS Cells; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Injections, Intraventricular; Luteinizing Hormone; Male; Neurosecretory Systems; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Receptors, Neuropeptide Y; Transfection | 2000 |
[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.
Topics: Animals; Arginine; Autoradiography; Binding Sites; Brain; Cell Line; Chloramines; DNA; In Vitro Techniques; Iodine Radioisotopes; Ligands; Male; Membranes; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tosyl Compounds; Transfection | 2000 |
Neuropeptide Y receptor(s) mediating feeding in the rat: characterization with antagonists.
Topics: Animals; Arginine; Diamines; Eating; Food Deprivation; Male; Naphthalenes; Pyrimidines; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
Orexin-induced food intake involves neuropeptide Y pathway.
Topics: Animals; Arginine; Carrier Proteins; Eating; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Neural Pathways; Neuropeptide Y; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y | 2000 |
Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Topics: Animals; Arginine; Autoradiography; Binding Sites; Binding, Competitive; Brain; Male; Naphthalenes; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Transfection | 2000 |
Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
Topics: Animals; Anxiety; Arginine; Dose-Response Relationship, Drug; Eating; Male; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Corticotropin; Receptors, Neuropeptide Y; Time Factors | 2000 |
Food intake regulation in rodents: Y5 or Y1 NPY receptors or both?
Topics: Animals; Arginine; Blood Pressure; CHO Cells; COS Cells; Cricetinae; Eating; Female; Humans; Male; Mice; Mice, Obese; Naphthalenes; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Injections, Intraventricular; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures.
Topics: Animals; Anticonvulsants; Arginine; Blotting, Western; Electroencephalography; Epilepsy; Hippocampus; Injections, Intraventricular; Kainic Acid; Kindling, Neurologic; Limbic System; Male; Neuronal Plasticity; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2000 |
Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat.
Topics: Animals; Arginine; Blood Pressure Determination; Disease Models, Animal; Hemodynamics; Hypertension, Renal; Injections, Intravenous; Kidney; Male; Neuropeptide Y; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Renin | 2000 |
Multiple Y receptors mediate pancreatic polypeptide responses in mouse colon mucosa.
Topics: Animals; Arginine; Binding, Competitive; Cloning, Molecular; Colon; Dose-Response Relationship, Drug; Electrophysiology; Female; Ion Transport; Male; Mice; Mucous Membrane; Pancreatic Polypeptide; Receptors, Neuropeptide Y | 2001 |
Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding.
Topics: Aging; Animals; Arginine; Brain; Cyclohexanes; Dietary Sucrose; Energy Intake; Homozygote; Humans; Mice; Mice, Knockout; Mice, Transgenic; Neuropeptide Y; Obesity; Phenotype; Promoter Regions, Genetic; Receptors, Neuropeptide Y; Reference Values; Thy-1 Antigens; Xanthenes | 2001 |
Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
Topics: Animals; Appetite; Arginine; Body Temperature; Brain; Carrier Proteins; Eating; Ghrelin; Growth Hormone; Immunohistochemistry; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Neurons; Neuropeptide Y; Neuropeptides; Oligopeptides; Orexins; Peptide Hormones; Peptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2002 |
The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat.
Topics: Animals; Arginine; Drug Combinations; Eating; Hypothalamic Hormones; Male; Melanins; Neuropeptide Y; Peptides, Cyclic; Pituitary Hormones; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2002 |
Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
Topics: Amides; Animals; Arginine; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Guinea Pigs; Male; Neuropeptide Y; Receptors, Neuropeptide Y | 2002 |
Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors.
Topics: Acute Disease; Animals; Arginine; Body Temperature; Carrageenan; Disease Models, Animal; Freund's Adjuvant; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Motor Activity; Neurogenic Inflammation; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Spinal Cord | 2002 |
Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
Topics: Animals; Arginine; Cells, Cultured; Concanavalin A; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Edema; Hydrogen Peroxide; Inflammation; Isoleucine; Macrophages; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thiazoles | 2002 |
Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.
Topics: Animals; Arginine; CHO Cells; Cricetinae; Humans; Receptors, Neuropeptide; Structure-Activity Relationship; Transfection | 2002 |
Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Topics: 5' Untranslated Regions; Alternative Splicing; Animals; Arginine; Base Sequence; Brain; Cloning, Molecular; Codon, Initiator; COS Cells; Humans; Molecular Sequence Data; Neuropeptide Y; Protein Biosynthesis; Protein Isoforms; Receptors, Neuropeptide Y; RNA, Messenger; Transcription, Genetic; Trinucleotide Repeats | 2003 |
Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y.
Topics: Animals; Arginine; Benzazepines; Disease Models, Animal; Disease Progression; Ganglia, Spinal; Hyperalgesia; Immune Sera; Ligation; Lumbosacral Region; Male; Medulla Oblongata; Microinjections; Nerve Crush; Neuropeptide Y; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Rhizotomy; Spinal Cord; Spinal Nerves | 2002 |
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Topics: Animals; Arginine; Benzazepines; Colon; Electric Stimulation; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Sex Characteristics; Tetrodotoxin | 2003 |
The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Topics: Animals; Arginine; Capillary Permeability; Dose-Response Relationship, Drug; Edema; Female; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Neutrophils; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Regional Blood Flow; Skin | 2003 |
Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
Topics: Amino Acid Sequence; Animals; Antigen-Presenting Cells; Arginine; Dose-Response Relationship, Immunologic; Encephalomyelitis, Autoimmune, Experimental; Epitopes, T-Lymphocyte; Female; Glycoproteins; Immunosuppressive Agents; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Molecular Sequence Data; Myelin-Oligodendrocyte Glycoprotein; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y; RNA, Messenger; T-Lymphocytes; Th1 Cells | 2003 |
Neuropeptide Y (NPY) delays the oestrogen-induced luteinizing hormone (LH) surge in the ovariectomized ewe: further evidence that NPY has a predominant negative effect on LH secretion in the ewe.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Cross-Over Studies; Down-Regulation; Estradiol; Estrus; Female; Gonadotropin-Releasing Hormone; In Situ Hybridization; Luteinizing Hormone; Neuropeptide Y; Ovariectomy; Ovulation; Progesterone; Receptors, Neuropeptide Y; Receptors, Progesterone; RNA, Messenger; Sheep | 2003 |
Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
Topics: Animals; Arginine; Body Weight; Eating; Energy Metabolism; Gastric Mucosa; Gene Expression; Ghrelin; Hyperphagia; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Peptide Hormones; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Thyrotoxicosis; Triiodothyronine | 2003 |
Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Topics: Animals; Arginine; Auditory Perception; Bradycardia; Conditioning, Psychological; Cues; Fear; Heart Rate; Male; Mice; Mice, Inbred C57BL; Neuropeptide Y; Receptors, Neuropeptide Y; Swine | 2004 |
Type 1 neuropeptide Y receptors and alpha1-adrenoceptors in the neural control of regional renal perfusion.
Topics: Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pressure; Heart Rate; Kidney; Male; Phenylephrine; Prazosin; Rabbits; Receptors, Adrenergic, alpha-1; Receptors, Neuropeptide Y | 2006 |
[Thyroid hormone and various other hormones regulate hypothalamic neuropeptide Y (NPY) expression and feeding behavior].
Topics: Animals; Arginine; Eating; Ghrelin; Hypothalamic Hormones; Hypothalamus; Insulin; Intracellular Signaling Peptides and Proteins; Leptin; Melanins; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Orexins; Peptide Hormones; Pituitary Hormones; Pro-Opiomelanocortin; Rats; Thyroid Hormones; Thyrotoxicosis; Triiodothyronine | 2006 |
Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors.
Topics: Analysis of Variance; Animals; Arginine; Behavior, Animal; Calcitonin Gene-Related Peptide; Capsaicin; Dose-Response Relationship, Drug; Drug Interactions; Hyperesthesia; Male; Neuropeptide Y; Pain Measurement; Peptide Fragments; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sensory Thresholds; Skin; Time Factors | 2006 |
The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y.
Topics: Amino Acids, Dicarboxylic; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Autoradiography; Dose-Response Relationship, Drug; Hippocampus; In Situ Hybridization; Male; Microinjections; Neuropeptide Y; Phosphoserine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; RNA, Messenger | 2007 |
Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Topics: Animals; Arginine; Benzazepines; Dopamine; Male; Naphthalenes; Neostriatum; Neuropeptide Y; Peptide Fragments; Peptide YY; Potassium Chloride; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stimulation, Chemical; Synaptic Transmission; Tyrosine | 2007 |
Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development.
Topics: Animals; Arginine; Brain; Brain Chemistry; Cyclohexanes; Eating; Female; Folic Acid; Genes, Lethal; Genes, Synthetic; Ghrelin; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; Neural Tube Defects; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide Hormones; Peptide YY; Pregnancy; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Teratogens; Vitamin A; Xanthenes | 2007 |
Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Arginine; Blood Pressure; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Hypertension; Male; Mesenteric Arteries; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Splanchnic Circulation; Superoxides; Sympathetic Nervous System | 2008 |
Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon.
Topics: Aged; Animals; Arginine; Benzazepines; Colon; Female; Humans; Intestinal Absorption; Male; Mice; Mice, Knockout; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y | 2008 |
Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arginine; Behavior, Animal; Disease Models, Animal; Hot Temperature; Hyperalgesia; Inflammation; Male; Mice; Mice, Knockout; Neuropeptide Y; Pain; Pain Measurement; Receptors, Neuropeptide Y; Sciatic Neuropathy | 2008 |
Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Age Factors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Captopril; Disease Models, Animal; Electric Stimulation; Hypertension; Imidazoles; Mesenteric Arteries; Neuropeptide Y; Prazosin; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System | 2008 |
The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.
Topics: Amygdala; Animals; Anxiety Disorders; Arginine; Brain; Conditioning, Psychological; Cues; Extinction, Psychological; Fear; Injections, Intraventricular; Male; Neuropeptide Y; Neuropsychological Tests; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reflex, Startle | 2008 |
Appetitive and consummatory ingestive behaviors stimulated by PVH and perifornical area NPY injections.
Topics: Animals; Appetitive Behavior; Arginine; Cricetinae; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Fornix, Brain; Male; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Phodopus; Receptors, Neuropeptide Y; Time Factors | 2009 |
Neuropeptide Y and gamma-melanocyte stimulating hormone (gamma-MSH) share a common pressor mechanism of action.
Topics: Animals; Arginine; Cardiovascular Physiological Phenomena; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Energy Metabolism; gamma-MSH; Hormone Antagonists; Humans; Male; Mice; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasomotor System | 2009 |
Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.
Topics: Amygdala; Analysis of Variance; Animals; Arginine; Conditioning, Classical; Dose-Response Relationship, Drug; Electroshock; Fear; Freezing Reaction, Cataleptic; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Models, Animal; Neuropeptide Y; Oligodeoxyribonucleotides, Antisense; Peptide Fragments; Receptors, Neuropeptide Y; Time Factors | 2009 |
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
Topics: Acoustic Stimulation; Animals; Arginine; Benzazepines; Conditioning, Operant; Corticotropin-Releasing Hormone; Fear; Male; Neuropeptide Y; Pyridazines; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y; Synaptic Transmission; Thiazoles; Time Factors | 2009 |
Attenuation of pain-related behavior evoked by injury through blockade of neuropeptide Y Y2 receptor.
Topics: Analysis of Variance; Animals; Arginine; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Motor Activity; Neuralgia; Neurons; Neuropeptide Y; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Rotarod Performance Test; Spinal Cord | 2011 |
Tonic inhibition of chronic pain by neuropeptide Y.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Chronic Disease; Gene Expression Regulation; Mice; Mice, Knockout; Neuropeptide Y; Nociceptors; Pain; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Receptors, Neuropeptide Y; Synaptic Transmission | 2011 |
A role for neuropeptide Y Y5 but not the Y1-receptor subtype in food deprivation-induced reinstatement of heroin seeking in the rat.
Topics: Animals; Arginine; Behavior, Animal; Benzothiepins; Dose-Response Relationship, Drug; Food Deprivation; Heroin; Male; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Recurrence; Self Administration; Sulfonamides | 2011 |
Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Arginine; Arousal; Behavior, Animal; Dose-Response Relationship, Drug; Electroshock; Environment; Feeding Behavior; Injections; Male; Neuropeptide Y; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Septum of Brain | 2011 |
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Arginine; Autoradiography; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Exploratory Behavior; Hippocampus; Interpersonal Relations; Male; Neuropeptide Y; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming; Time Factors | 2012 |
The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.
Topics: Animals; Arginine; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Humans; Male; Maze Learning; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reflex, Startle; Resilience, Psychological; Stress Disorders, Post-Traumatic; Stress, Psychological | 2012 |
A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress.
Topics: Animals; Arginine; Benzazepines; Corticosterone; Eating; Female; Gastrointestinal Motility; Gastrointestinal Tract; Male; Mice; Mice, Knockout; Neuropeptide Y; Restraint, Physical; Sex Factors; Stress, Physiological | 2012 |
Neuropeptide Y Y1 receptor antagonism increases bone mass in mice.
Topics: Animals; Arginine; Bone Density; Dose-Response Relationship, Drug; Glucose; Homeostasis; Male; Mice; Mice, Inbred C57BL; Osteogenesis; Receptors, Neuropeptide Y | 2012 |
Involvement of neuropeptide Y signaling in the antidepressant-like effect and hippocampal cell proliferation induced by kososan, a Kampo medicine, in the stress-induced depression-like model mice.
Topics: Animals; Antidepressive Agents; Arginine; Cell Proliferation; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Intracellular Signaling Peptides and Proteins; Male; Medicine, Kampo; Mice; Neuropeptide Y; Neuropeptides; Orexins; Signal Transduction; Stress, Psychological | 2012 |
Differences in neuropeptide Y-induced secretion of endothelin-1 in left and right human endocardial endothelial cells.
Topics: Arginine; Endocardium; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Microscopy, Confocal; Neuropeptide Y; Radioimmunoassay; Receptors, Neuropeptide Y | 2012 |
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
Topics: Arginine; Dimerization; Fura-2; Guanidine; Humans; Models, Molecular; Protein Binding; Receptors, Neuropeptide Y; Stereoisomerism; Structure-Activity Relationship; Urea | 2013 |
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.
Topics: Adult; Animals; Arginine; Cell Proliferation; Epinephrine; Female; Humans; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Indoles; Lung; Male; Mice, Inbred C57BL; Monocrotaline; Myocytes, Smooth Muscle; Neuropeptide Y; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2014 |
Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times.
Topics: Administration, Intranasal; Amygdala; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Circadian Rhythm; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Male; Maze Learning; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Psychological Trauma; Rats; Receptors, Neuropeptide Y; Reflex, Startle; Stress, Psychological; Time Factors | 2015 |
Toward Labeled Argininamide-Type NPY Y1 Receptor Antagonists: Identification of a Favorable Propionylation Site in BIBO3304.
Topics: Animals; Arginine; Binding Sites; Binding, Competitive; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Design; Ligands; Molecular Structure; Propionates; Protein Binding; Radioligand Assay; Receptors, Neuropeptide Y; Structure-Activity Relationship; Transfection | 2015 |
Neuropeptide Y Impairs Retrieval of Extinguished Fear and Modulates Excitability of Neurons in the Infralimbic Prefrontal Cortex.
Topics: Animals; Arginine; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Fear; Glutamate Decarboxylase; Learning Disabilities; Male; Mental Recall; Neurons; Neuropeptide Y; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synaptic Potentials | 2016 |
Ghrelin activates hypophysiotropic corticotropin-releasing factor neurons independently of the arcuate nucleus.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Corticosterone; Corticotropin-Releasing Hormone; GABA Antagonists; gamma-Aminobutyric Acid; Gene Knockdown Techniques; Ghrelin; Infusions, Intraventricular; Male; Mice; Muscimol; Neurons; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Receptors, Ghrelin | 2016 |
Insulin increases sympathetic nerve activity in part by suppression of tonic inhibitory neuropeptide Y inputs into the paraventricular nucleus in female rats.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Female; Heart Rate; Hypoglycemic Agents; Insulin; Melanocyte-Stimulating Hormones; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Sympathetic Nervous System | 2016 |
Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice.
Topics: Animals; Arginine; Benzazepines; Brain; Discrimination, Psychological; Infusions, Intraventricular; Male; Memory; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Social Behavior | 2017 |
Inhibition of Y1 receptor signaling improves islet transplant outcome.
Topics: Animals; Arginine; Cyclic AMP; Diabetes Mellitus, Experimental; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Receptors, Neuropeptide Y; Signal Transduction | 2017 |
Kisspeptin Stimulates Growth Hormone Release by Utilizing Neuropeptide Y Pathways and Is Dependent on the Presence of Ghrelin in the Ewe.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Atropine; Fasting; Female; Fluorescent Antibody Technique; Ghrelin; Growth Hormone; Growth Hormone-Releasing Hormone; Kisspeptins; Muscarinic Antagonists; Neuropeptide Y; Oligopeptides; Proto-Oncogene Proteins c-fos; Receptors, Ghrelin; Receptors, Neuropeptide Y; Sheep; Sheep, Domestic; Somatostatin-Secreting Cells | 2017 |
Gas-phase structural characterization of neuropeptides Y Y1 receptor antagonists using mass spectrometry: Orbitrap vs triple quadrupole.
Topics: Arginine; Limit of Detection; Receptors, Neuropeptide Y; Tandem Mass Spectrometry | 2018 |
Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Cancer Pain; Female; Male; Musculoskeletal Pain; Neuropeptide Y; Nociception; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Spinal Cord Dorsal Horn | 2018 |
Effect of orexin-A in the arcuate nucleus on cisplatin-induced gastric side effects in rats.
Topics: Action Potentials; Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Arginine; Cisplatin; Eating; Gastric Emptying; Gastrointestinal Motility; Infusions, Intraventricular; Male; Neurons; Orexins; Pica; Random Allocation; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger; Stomach | 2019 |
Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Baroreflex; Female; Insulin; Male; Neural Inhibition; Neuropeptide Y; Obesity; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sex Factors; Sympathetic Nervous System | 2019 |
Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
Topics: Animals; Arginine; Benzazepines; Cues; Extinction, Psychological; Fear; Memory; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Time Factors | 2019 |
An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain.
Topics: Animals; Arginine; Chronic Pain; Cyclic AMP-Dependent Protein Kinases; Guanine Nucleotide Exchange Factors; Hyperalgesia; Inflammation; Male; Mice; Pain Measurement; Pain Threshold; Phosphorylation; Receptors, Neuropeptide Y | 2019 |
Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arginine; Calcium Channel Blockers; Capsaicin; Cyclic AMP-Dependent Protein Kinases; Excitatory Amino Acid Antagonists; Hyperalgesia; Indoles; Interneurons; Lidocaine; Male; Microscopy, Confocal; Neuropeptide Y; Nociception; omega-Conotoxins; Peripheral Nerve Injuries; Posterior Horn Cells; Potassium Chloride; Protein Transport; Protein Tyrosine Phosphatases; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide Y; Sensory System Agents; Spinal Cord; Spinal Nerve Roots; TRPV Cation Channels; Voltage-Gated Sodium Channel Blockers | 2019 |
Neuropeptide Y1 receptor antagonist promotes osteoporosis and microdamage repair and enhances osteogenic differentiation of bone marrow stem cells via cAMP/PKA/CREB pathway.
Topics: Aged; Animals; Arginine; Bone Marrow Cells; Cell Differentiation; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Female; Humans; Male; Osteogenesis; Osteoporosis; Rats; Receptors, Neuropeptide Y; X-Ray Microtomography | 2020 |
Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arginine; Disease Models, Animal; Neuropeptide Y; Receptors, Neuropeptide Y; Sus scrofa; Sympathetic Nervous System; Tachycardia, Ventricular | 2020 |
Peripheral-specific Y1 receptor antagonism increases thermogenesis and protects against diet-induced obesity.
Topics: Adipocytes; Adipose Tissue, Brown; Adult; Animals; Arginine; Biopsy; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Energy Metabolism; Female; Humans; Male; Mice; Middle Aged; Obesity; Primary Cell Culture; Receptors, Neuropeptide Y; Thermogenesis | 2021 |
Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
Topics: Amygdala; Animals; Arginine; Benzazepines; Fear; Male; Mice; Neuropeptide Y; Phobia, Social; Receptors, Neuropeptide Y; Septum of Brain | 2021 |
Restraint stress potentiates neuropeptide Y-mediated impairment on spatial memory in rats.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Disease Models, Animal; Male; Memory Disorders; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Restraint, Physical; Spatial Memory; Stress, Psychological | 2022 |
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Glucose; Glycemic Control; Insulin; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Neuropeptide Y; Obesity; Receptors, Neuropeptide Y | 2022 |